Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib for Anti-IFN-Gamma Autoantibody Associated Immunodeficiency
NCT03103555Phase 2Unknown
- Sponsor
- Mahidol University
- Start
- Feb 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies (AOID), sponsored by Mahidol University. Status: unknown.
02
Drugs
bortezomib
03
Conditions
Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies (AOID)
Beyond the preview
Go deeper on NCT03103555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03103555.